Skip to content

Christopher Jenks

3 papers in the library · 70 citations · publishing 2002-2020

Papers

Sort Most recent Most cited

Quantitative Evaluation of a Mexican and a Ghanaian Tabernaemontana Species as Alternatives to Voacanga africana for the Production of Antiaddictive Ibogan Type Alkaloids.

Chemistry & Biodiversity May 1, 2020 Felix Krengel, Jonathan Dickinson, Christopher Jenks et al. 7 citations

In continuation of our efforts to provide quantitative information on antiaddictive ibogan type alkaloid-producing Tabernaemontana species, we used gas chromatography-mass spectrometry (GC/MS) to compare the alkaloid profiles of the barks and/or leaves of one Mexican and one African species - T. arborea and T. crassa, respectively, with the primary sources of commercially available...

An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers

Archives of Clinical Psychiatry (São Paulo) April 1, 2020 José Carlos Bouso, I. Fornís, Mireia Ventura et al. 15 citations

Background: Therapeutic properties of ibogaine in the treatment of addiction are attracting both clinicians and patients to its use. Since ibogaine is not an authorized medicine, the quality of these products is not always known, increasing the probability of adverse reactions. Objective: This study collects different types of iboga-derived samples from treatment providers, vendors and online...

Extraction studies of Tabernanthe iboga and Voacanga africana.

Natural product letters February 1, 2002 Christopher Jenks 48 citations

The root bark of Tabernanthe iboga contains ibogaine as its predominant alkaloid and has been an important source of it. Ibogaine is used experimentally to interrupt drug addiction and allow therapeutic intervention, but is currently unaffordable to doctors in less economically developed countries. To meet this need, an extraction of alkaloids from T. iboga root bark was optimized and...